Pancreatic Cancer Research

ResearcherF. Hoffmann-La Roche AGNo recent work listed

Christian Klein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7594-7280; OpenAlex author ID A5067162282. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 3

  1. Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis. Co-author DOI 10.1016/j.ccell.2023.04.001↗
  2. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.molpharmaceut.3c00453↗
  3. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatme… Last author DOI 10.1080/19420862.2016.1160989↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sanne A. M. van Lith · 1 shared paper, 2023 · strength 0.17
  2. Phyllis F. Cheung · 1 shared paper, 2023 · strength 0.17
  3. Marija Trajkovic‐Arsic · 1 shared paper, 2023 · strength 0.17
  4. Erik H.J.G. Aarntzen · 1 shared paper, 2023 · strength 0.17
  5. E. Smeets · 1 shared paper, 2023 · strength 0.17
  6. Daphne N. Dorst · 1 shared paper, 2023 · strength 0.17
  7. Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.17
  8. Martijn W.J. Stommel · 1 shared paper, 2023 · strength 0.17
  9. Martin Gotthardt · 1 shared paper, 2023 · strength 0.17
  10. Miles Piper · 1 shared paper, 2023 · strength 0.13
  11. Sana D. Karam · 1 shared paper, 2023 · strength 0.13
  12. Angelo D’Alessandro · 1 shared paper, 2023 · strength 0.13
  13. Juergen M. Schanzer · 1 shared paper, 2016 · strength 0.05
  14. Peng Wang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.